Virtue Diagnostics
PrivateLast Round
Series B
Jan 6, 2022
Total Funding Raised
$130.6M
Company Overview
Virtue Diagnostics is an innovative in vitro diagnostics (IVD) company that develops and manufactures diagnostic solutions for infectious diseases, cancer, maternal and fetal health, and chronic diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Virtue Diagnostics Comparables
Compare Virtue Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Maccura Biotechnology Co Ltd | 75% | |
| Shenzhen New Industries Biomedical Engineering | 74% | |
| Autobio Diagnostics Co Ltd | 74% |
Virtue Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 6, 2022 | ||||
| Series A | Dec 18, 2020 |
Virtue Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oriza Holdings | Series B |
| Morningside Ventures | Series B |
| Lilly Asia Ventures | Series B, Series A |
| Lilly Asia Ventures | Series B, Series A |
| HongShan Capital Group (HSG) | Series B |
Recent news
Latest coverage and updates
- expands_facilitiesSep 3, 2026
Virtuedx expanded facilities to Indonesia, South-eastern Asia, Asia on Jul 1st '24.
- launchesJul 28, 2026
Virtuedx launched QSight 420 Mass Spectrometry system on Jul 1st '20.
Virtue Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Virtue Diagnostics's valuation, stock price, and market status.
Is Virtue Diagnostics a public or private company?
Virtue Diagnostics is a private company.
What is the current stock price of Virtue Diagnostics?
Virtue Diagnostics is a private company with no public stock price. No recent secondary market data is available.
How much is Virtue Diagnostics worth (valuation)?
Valuation information for Virtue Diagnostics is not publicly available.
Can I buy Virtue Diagnostics stock?
Virtue Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Virtue Diagnostics's last funding round?
Virtue Diagnostics's most recent funding round was Series B on January 6, 2022.
Who are the main investors in Virtue Diagnostics?
Key investors in Virtue Diagnostics include Oriza Holdings, Morningside Ventures, Lilly Asia Ventures, HongShan.
Will Virtue Diagnostics IPO soon?
No public IPO plans have been announced for Virtue Diagnostics.
How can I track Virtue Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Virtue Diagnostics's secondary market activity and sign up for updates.